Pathologic changes in the non-carcinomatous epithelium of the gallbladder in patients with a relatively long common channel

Gastrointestinal Endoscopy

Volumn 60, Issue 1, 2004, Pages 56-60

  Kamisawa, Terumi ^a   Funata, Nobuaki ^b   Hayashi, Yukiko ^b   Egawa, Naoto ^b   Nakajima, Hitoshi ^b   Tsuruta, Kouji ^b   Okamoto, Atsutake ^b   Yamaguchi, Toshikazu ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; BILE DUCT; CELL PROLIFERATION; CONGENITAL MALFORMATION; EPITHELIUM; GALLBLADDER CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; LABELING INDEX; MAJOR CLINICAL STUDY; ONCOGENE K RAS; PANCREAS DUCT; PANCREAS MALFORMATION; PANCREATICOBILIARY MALJUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOGRAPHY; SPHINCTER; STATISTICAL SIGNIFICANCE;

BILE DUCTS; EPITHELIUM; GALLBLADDER; GALLBLADDER NEOPLASMS; GENES, RAS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MUTATION; PANCREATIC DUCTS; RETROSPECTIVE STUDIES; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 3042587202     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(04)01290-8     Document Type: Article

References (21)

1. Funabiki T., Matsubara T., Ochiai M., Sakurai Y., Hasegawa S. Diagnostic criteria of pancreaticobiliary maljunction. Koyanagi Y., Aoki T. Pancreaticobiliary maljunction. 2002;23-30 Igaku Tosho, Tokyo
2. Kimura K., Ohto M., Ono T., Tsuchiya Y., Saisho H., Kawamura K., et al. Congenital cystic dilatation of the common bile duct: relationship to anomalous pancreaticobiliary ductal union. AJR Am J Roentgenol. 128:1977;571-577
3. Tashiro S., Imaizumi T., Ohkawa H., Okada A., Katoh T., Kawarada Y., et al. Overall report on the registration study of the Japanese Study Group on Pancreaticobiliary Maljunction for the past 10 years. Koyanagi Y., Aoki T. Pancreaticobiliary maljunction. 2002;401-410 Igaku Tosho, Tokyo
4. Sugiyama M., Atomi Y. Anomalous pancreaticobiliary junction without congenital choledochal cyst. Br J Surg. 85:1998;911-916
5. Hanada K., Tsuchida A., Iwao T., Eguchi N., Sasaki T., Morinaka K., et al. Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol. 94:1999;1638-1643
6. Matsubara T., Sakurai Y., Zhi L.Z., Miura H., Ochiai M., Funabiki T. K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 9:2002;312-321
7. Nagai M., Watanabe M., Iwase T., Yamao K., Isaji S. Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg. 26:2002;91-98
8. Sterling J.A. The common channel for bile and pancreatic ducts. Surg Gynecol Obstet. 98:1954;420-424
9. Dowdy G.S., Waldron G.W., Brown W.D. Surgical anatomy of the pancreaticobiliary ductal system. Arch Surg. 84:1962;229-246
10. Skandalakis J.E., Gray S.W., Rowe J.S., Skandalakis L.J. Anatomical complications of pancreatic surgery. Contemp Surg. 15:1979;17-40
11. Kamisawa T., Amemiya K., Tu Y., Egawa N., Sakaki N., Tsuruta K., et al. Clinical significance of a long common channel. Pancreatology. 2:2002;122-128
12. Kamisawa T., Tu Y., Egawa N., Ishiwata J., Tsuruta K., Okamoto A., et al. Ductal and acinar differentiation in pancreatic endocrine tumors. Dig Dis Sci. 47:2002;2254-2261
13. Sai J.K., Ariyama J., Suyama T., Kubokawa Y., Sato N. Occult regurgitation of pancreatic juice into the biliary tract: diagnosis with secretin injection magnetic resonance cholangiopancreatography. Gastrointest Endosc. 56:2002;929-932
14. Marks F., Bertsch S., Grimm W., Schweizer J. Hyperplastic transformation and tumor promotion in mouse epidermis: possible consequences of disturbances of endogenous mechanism controlling proliferation and differentiation. Carcinogenesis. 2:1978;97-116
15. Argyris T.S. Tumor promotion by damage-induced epidermal hyperplasia in the skin of mice. Proc Am Assoc Cancer Res. 20:1979;4
16. Slaga T.J., Scribner J.D. Inhibition of tumor initiation and promotion by anti-inflammatory agents. J Natl Cancer Inst. 51:1973;1723-1725
17. Cameron R., Lee G., Farber E. Chemical mitogens as effective alternatives to partial hepatectomy in the new model for the sequential analysis of hepatocarcinogenesis. Proc Am Assoc Cancer Res. 19:1978;56
18. Linder S., Parrado C., Falkmer U.G., Blasjo M., Sundelin P., Rosen A. Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: a study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material. Br J Cancer. 76:1997;54-59
19. Broll R., Mahlke C., Best R., Schimmelpenning H., Strik M.W., Schiedeck Th, et al. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1. J Cancer Res Clin Oncol. 124:1998;49-54
20. Tanno S., Obara T., Fujii T., Mizukami Y., Shudo R., Nishino N., et al. Proliferative potential and K-ras mutation in epithelial hyperplasia of the gallbladder in patients with anomalous pancreaticobiliary ductal union. Cancer. 83:1998;267-275
21. Matsubara T., Funabiki T., Jinno O., Sakurai Y., Hasegawa S., Imazu H., et al. p53 gene mutations and overexpression of p53 product in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg. 6:1999;286-293